Epigenetic modifications are known to regulate cell phenotype during cancer progression, including breast cancer. Unlike genetic alterations, changes in the epigenome are reversible, thus potentially reversed by epi-drugs. Breast cancer, the most common cause of cancer death worldwide in women, encompasses multiple histopathological and molecular subtypes. Several lines of evidence demonstrated distortion of the epigenetic landscape in breast cancer. Interestingly, mammary cells isolated from breast cancer patients and cultured ex vivo maintained the tumorigenic phenotype and exhibited aberrant epigenetic modifications. Recent studies indicated that the therapeutic efficiency for breast cancer regimens has increased over time, resulting in reduced mortality. Future medical treatment for breast cancer patients, however, will likely depend upon a better understanding of epigenetic modifications. The present review aims to outline different epigenetic mechanisms including DNA methylation, histone modifications, and ncRNAs with their impact on breast cancer, as well as to discuss studies highlighting the central role of epigenetic mechanisms in breast cancer pathogenesis. We propose new research areas that may facilitate locus-specific epigenome editing as breast cancer therapeutics.
Environmental factors, including pollutants and lifestyle, constitute a significant role in severe, chronic pathologies with an essential societal, economic burden. The measurement of all environmental exposures and assessing their correlation with effects on individual health is defined as the exposome, which interacts with our unique characteristics such as genetics, physiology, and epigenetics. Epigenetics investigates modifications in the expression of genes that do not depend on the underlying DNA sequence. Some studies have confirmed that environmental factors may promote disease in individuals or subsequent progeny through epigenetic alterations. Variations in the epigenetic machinery cause a spectrum of different disorders since these mechanisms are more sensitive to the environment than the genome, due to the inherent reversible nature of the epigenetic landscape. Several epigenetic mechanisms, including modifications in DNA (e.g., methylation), histones, and noncoding RNAs can change genome expression under the exogenous influence. Notably, the role of long noncoding RNAs in epigenetic processes has not been well explored in the context of exposome-induced tumorigenesis. In the present review, our scope is to provide relevant evidence indicating that epigenetic alterations mediate those detrimental effects caused by exposure to environmental toxicants, focusing mainly on a multi-step regulation by diverse noncoding RNAs subtypes.
La contaminación del aire es un problema global con graves consecuencias para la salud humana. Los contaminantes como el polvo, el humo o los gases tóxicos afectan la esperanza de vida e incrementan la incidencia de enfermedades respiratorias, cardiovasculares y diversos tipos de cáncer. Las ciudades, con su alta actividad industrial y tráfico vehicular, son especialmente vulnerables a estos efectos. Además, la contaminación atmosférica puede desplazarse a través de fronteras, afectando comunidades más allá de su origen, lo que convierte la protección del aire en una responsabilidad compartida. Para abordar esta problemática, se han implementado tecnologías y políticas de mitigación, como la prohibición de clorofluorocarbonos, la reducción de partículas emitidas por plantas de energía y la adopción de convertidores catalíticos en vehículos. Estos avances demuestran que mejorar la calidad del aire es posible mediante esfuerzos coordinados. Investigaciones en ciencias ómicas, como la genómica y epigenómica, ayudan a entender cómo los contaminantes afectan la salud a nivel molecular, permitiendo identificar biomarcadores de exposición y diseñar intervenciones preventivas y personalizadas. Este artículo examina la situación en la ciudad de Puebla, México, donde el crecimiento urbano y la actividad industrial elevan las emisiones de PM2.5 y PM10, partículas vinculadas con enfermedades crónicas. Se analizan las tendencias de estas emisiones y los esfuerzos locales e internacionales de mitigación. La meta es ofrecer una visión integral sobre el impacto de la contaminación del aire en la salud y destacar la urgencia de fortalecer las estrategias de control ambiental en áreas vulnerables.